XML 23 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED) - USD ($)
$ in Thousands
6 Months Ended
Jul. 31, 2016
Jul. 31, 2015
Cash flow from operating activities:    
Net loss $ (14,113) $ (24,712)
Adjustments to reconcile net loss to cash flow from operating activities:    
Depreciation and amortization 13,382 20,228
Bad debt expense 1,334 269
Amortization of discount and deferred financing costs 2,072 2,119
Gain on extinguishment of debt   (4,236)
Deferred income taxes (28) (3,378)
Equity-based compensation 2,092 2,397
Equity in earnings of affiliates (1,727) 685
Dividends received from affiliates 2,438 2,926
Restructuring costs 1,460 3,245
Write-down of inventory   7,563
Impairment charges   4,598
Gain from disposal of property and equipment (253) (950)
Changes in current assets and liabilities:    
Customer receivables (1,418) 2,775
Costs and estimated earnings in excess of billings on uncompleted contracts (514) (3,203)
Inventories 835 1,735
Other current assets 356 3,168
Accounts payable and accrued expenses (8,851) (15,171)
Billings in excess of costs and estimated earnings on uncompleted contracts 3,573 (6,171)
Other, net (1,490) 2,983
Cash used in operating activities (2,312) (3,130)
Cash flow from investing activities:    
Additions to property and equipment (7,731) (9,693)
Proceeds from disposal of property and equipment 1,484 5,882
Release of cash from restricted accounts 1,944 677
Cash used in investing activities (4,303) (3,134)
Cash flow from financing activities:    
Repayments under revolving loan facilities   (22,039)
Proceeds from 8.0% convertible notes   49,950
Payment of debt issuance costs (8) (5,268)
Principal payments under capital lease obligation (60) (101)
Purchases and retirement of treasury stock   (342)
Cash (used in) provided by financing activities (68) 22,200
Effects of exchange rate changes on cash 55 546
Net (decrease) increase in cash and cash equivalents (6,628) 16,482
Cash and cash equivalents at beginning of period 65,569 21,661
Cash and cash equivalents at end of period $ 58,941 $ 38,143